Welcome to drugdiscoveryanddevelopment.co.uk
Click to listen highlighted text!
Welcome to drugdiscoveryanddevelopment.co.uk
Subscribe to newsletter
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Tue 22 September 2026
A Pharma Press Global company
Subscribe to DDD newsletter
Search
Drug Discovery and Development
Drug Discovery
Investigational New Drug application
Phase 1-2 trials
Phase 3 trials
Approvals
Finance
Conferences
Journal
Drug Discovery
Investigational New Drug application
Phase 1-2 trials
Phase 3 trials
Approvals
Novartis remibrutinib significantly reduces relapse rates and shows favourable safety profile in phase 3 RMS trials
9 September 2026
GSK to advance mRNA seasonal flu vaccine candidate to phase 3 following positive phase 2 data
9 September 2026
New phase 3b data on Eli Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults...
8 September 2026
Acoramidis demonstrates reversal of cardiac structural disease progression and functional decline and significantly increases days alive and free from hospitalisation in ATTR-CM
8 September 2026
Tezspire demonstrates positive phase 3 results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
8 September 2026
Products
CDMO
CRO
Home
Authors
Posts by Editor
Editor
162 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Aurora Cannabis furthers global medical cannabis growth with accretive acquisition of Internode Pharma and HAP Pharma
Editor
-
28 August 2026
0
Conferences and events
CPHI & PMEC Shenzhen 2026 attracts unprecedented international interest as demand for AI-driven innovation grows
Editor
-
28 August 2026
0
Drug Delivery and Supply Chain
FUJIFILM Biotechnologies selected in FDA precheck pilot programme to advance US drug manufacturing
Editor
-
28 August 2026
0
Finance, mergers and appointments
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across US, Europe and India
Editor
-
28 August 2026
0
Finance, mergers and appointments
Lonza expands strategic collaboration with leading US biopharmaceutical company
Editor
-
24 August 2026
0
Finance, mergers and appointments
NurExone signs exclusive US GMP manufacturing partnership with made scientific
Editor
-
24 August 2026
0
Conferences and events
US Pharmacopeia to host sessions at 2026 AAPS PharmSci 360
Editor
-
17 August 2026
0
Conferences and events
Sustainability, AI and resilience take centre stage at CPHI Milan 2026
Editor
-
13 August 2026
0
Phase 3 trials
Novo Nordisk provides update on a phase 3 trial in people with ASCVD, CKD and inflammation
Editor
-
13 August 2026
0
Phase 3 trials
Kodiak Sciences completes enrolment in first pivotal cohort in the phase 3 trial of KSI-101 for macular oedema secondary to inflammation and reaffirms topline...
Editor
-
13 August 2026
0
1
2
3
4
...
17
Page 3 of 17
TOP AUTHORS
Editor
162 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Julian English
36 POSTS
0 COMMENTS
https://drugdiscoveryanddevelopment.co.uk
Most Read
Novartis remibrutinib significantly reduces relapse rates and shows favourable safety profile in phase 3 RMS trials
9 September 2026
GSK to advance mRNA seasonal flu vaccine candidate to phase 3 following positive phase 2 data
9 September 2026
New phase 3b data on Eli Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults...
8 September 2026
Acoramidis demonstrates reversal of cardiac structural disease progression and functional decline and significantly increases days alive and free from hospitalisation in ATTR-CM
8 September 2026
Click to listen highlighted text!